Literature DB >> 19913579

Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.

Umesh Gupta1, Narendra K Jain.   

Abstract

Development of an effective drug delivery approach for the treatment of HIV/AIDS is a global challenge. The conventional drug delivery approaches including Highly Active Anti Retroviral Therapy (HAART) have increased the life span of the HIV/AIDS patient. However, the eradication of HIV is still not possible with these approaches due to some limitations. Emergence of polymeric and non-polymeric nanotechnological approaches can be opportunistic in this direction. Polymeric carriers like, dendrimers and nanoparticles have been reported for the targeting of anti HIV drugs. The synthetic pathways as well polymeric framework create some hurdles in their successful formulation development as well as in the possible drug delivery approaches. In the present article, we have discussed the general physiological aspects of the infection along with the relevance of non-polymeric nanocarriers like liposomes, solid lipid nanoparticles (SLN), ethosomes, etc. in the treatment of this disastrous disease. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913579     DOI: 10.1016/j.addr.2009.11.018

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  28 in total

Review 1.  Towards nanomedicines for neuroAIDS.

Authors:  Vidya Sagar; Sudheesh Pilakka-Kanthikeel; Ravi Pottathil; Shailendra K Saxena; Madhavan Nair
Journal:  Rev Med Virol       Date:  2014-01-07       Impact factor: 6.989

Review 2.  Single-chain polymer nanoparticles.

Authors:  Miren Karmele Aiertza; Ibon Odriozola; Germán Cabañero; Hans-Jürgen Grande; Iraida Loinaz
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

3.  Liposomes as nanocarriers for anti-HIV therapy.

Authors:  Shruti Chopra; Natarajan Venkatesan; Guru V Betageri
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

Review 4.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

5.  Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.

Authors:  Jijin Gu; Karam Al-Bayati; Emmanuel A Ho
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

Review 6.  The potential of magneto-electric nanocarriers for drug delivery.

Authors:  Ajeet Kaushik; Rahul Dev Jayant; Vidya Sagar; Madhavan Nair
Journal:  Expert Opin Drug Deliv       Date:  2014-07-02       Impact factor: 6.648

Review 7.  Investigational protease inhibitors as antiretroviral therapies.

Authors:  Narasimha M Midde; Benjamin J Patters; Pss Rao; Theodore J Cory; Santosh Kumar
Journal:  Expert Opin Investig Drugs       Date:  2016-08-02       Impact factor: 6.206

Review 8.  Nanoparticle transport across the blood brain barrier.

Authors:  Andreas M Grabrucker; Barbara Ruozi; Daniela Belletti; Francesca Pederzoli; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  Tissue Barriers       Date:  2016-02-25

9.  Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment.

Authors:  Asahi Tomitaka; Hamed Arami; Zaohua Huang; Andrea Raymond; Elizette Rodriguez; Yong Cai; Marcelo Febo; Yasushi Takemura; Madhavan Nair
Journal:  Nanoscale       Date:  2017-12-21       Impact factor: 7.790

Review 10.  Progress in antiretroviral drug delivery using nanotechnology.

Authors:  Rama Mallipeddi; Lisa Cencia Rohan
Journal:  Int J Nanomedicine       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.